Publication | Open Access

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study

Dose-escalation StudyHematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaPharmacotherapyOncologyRadiation OncologyPhase 1Health Sciences